Scpharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $12,150 | $10,026 | $8,054 | $6,102 |
Gross Profit | 8,185 | 6,715 | 5,754 | 4,266 |
EBITDA | -17,356 | -33,250 | -14,904 | -11,956 |
EBIT | -17,360 | -33,163 | -14,956 | -12,007 |
Net Income | -18,845 | -35,105 | -17,090 | -14,108 |
Net Change In Cash | 12,150 | 10,026 | 8,054 | 6,102 |
Free Cash Flow | -15,198 | -17,433 | -20,227 | -17,701 |
Cash | 75,655 | 91,484 | 38,504 | 58,447 |
Basic Shares | 44,519 | 46,558 | 38,984 | 38,952 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $36,332 | $13,593 | $2,063 | $0 |
Gross Profit | 24,971 | 9,782 | -468 | -438 |
EBITDA | -77,558 | -46,061 | -33,068 | -25,021 |
EBIT | -77,578 | -46,687 | -33,536 | -25,459 |
Net Income | -85,148 | -54,810 | -37,519 | -30,486 |
Net Change In Cash | 36,332 | 13,593 | 2,063 | 0 |
Cost of Revenue | -3,207 | 2,449 | ||
Free Cash Flow | -70,559 | -59,284 | -34,598 | -27,160 |
Cash | 75,655 | 46,814 | 71,061 | 74,268 |
Basic Shares | 44,519 | 38,513 | 28,358 | 27,351 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.31 |
2024-09-30 | -$0.28 |
2024-06-30 | -$0.44 |
2024-03-31 | -$0.36 |
